Company Overview - Tailin Biological Technology Co., Ltd. is located in Hangzhou, Zhejiang Province, established on January 8, 2002, and listed on January 14, 2020. The company specializes in the research, manufacturing, and sales of microbial detection and control technology systems, organic analysis instruments, and other pharmaceutical equipment [1]. Business Segmentation - The main business revenue composition is as follows: microbial detection technology series products account for 41.12%, sterile production and contamination control equipment series products account for 40.78%, organic analysis technology series products account for 11.15%, and others account for 6.95% [1]. Stock Performance - On October 27, Tailin Biological's stock fell by 5.14%, trading at 30.44 yuan per share, with a transaction volume of 85.03 million yuan and a turnover rate of 3.58%. The total market capitalization is 3.689 billion yuan [1]. Fund Holdings - According to data from major fund holdings, one fund under Nuoan Fund has a significant position in Tailin Biological. The Nuoan Multi-Strategy Mixed A Fund (320016) increased its holdings by 286,000 shares in the second quarter, bringing the total to 511,200 shares, which represents 0.44% of the fund's net value, making it the fourth-largest holding [2]. Fund Performance - The Nuoan Multi-Strategy Mixed A Fund (320016) was established on August 9, 2011, with a latest scale of 1.399 billion yuan. Year-to-date returns are 68.76%, ranking 345 out of 8,226 in its category; one-year returns are 84.01%, ranking 158 out of 8,099; and since inception, the return is 225.7% [2]. Fund Management - The fund is managed by Kong Xianzheng and Wang Haichang. As of the latest update, Kong has been in position for 4 years and 336 days, with a total fund asset size of 4.607 billion yuan, achieving a best return of 84.01% and a worst return of -16.74% during his tenure. Wang has been in position for 3 years and 98 days, managing assets of 2.529 billion yuan, with a best return of 71.06% and a worst return of -18.8% [3].
泰林生物股价跌5.14%,诺安基金旗下1只基金重仓,持有51.12万股浮亏损失84.35万元